Compare RVMD & LLYVK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RVMD | LLYVK |
|---|---|---|
| Founded | 2014 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Broadcasting |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2B | 8.6B |
| IPO Year | N/A | N/A |
| Metric | RVMD | LLYVK |
|---|---|---|
| Price | $98.94 | $95.43 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 16 | 0 |
| Target Price | ★ $114.63 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 349.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $454.85 | $9.89 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $29.17 | $60.55 |
| 52 Week High | $124.49 | $102.14 |
| Indicator | RVMD | LLYVK |
|---|---|---|
| Relative Strength Index (RSI) | 49.47 | 51.75 |
| Support Level | $93.59 | $94.62 |
| Resistance Level | $107.45 | $101.99 |
| Average True Range (ATR) | 3.89 | 3.92 |
| MACD | -0.58 | -0.92 |
| Stochastic Oscillator | 33.33 | 46.14 |
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
Liberty Live Holdings Inc focuses on live entertainment investments. The company maintains a substantial ownership position in Live Nation Entertainment, the primary international promoter of concerts, events, and ticketing through platforms like Ticketmaster, alongside sponsorship and hospitality services via QuintEvents.